Humacyte, Inc. (HUMA) Reports Q3 Loss, Misses Revenue Estimates

Humacyte, Inc. (HUMA) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of$ 0.17. This compares to a loss of $0.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +17.65%. A quarter ago, it was expected that this company would post a loss of$ 0.15 per share when it actually produced a loss of $0.24, delivering a surprise of -60%.Over the last four quarters, the company has surpasse ...